These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28012100)

  • 21. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
    Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
    Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for encapsulating peritoneal sclerosis in long-term peritoneal dialysis: a retrospective observational study.
    Nakao M; Yokoyama K; Yamamoto I; Matsuo N; Tanno Y; Ohkido I; Hayakawa H; Ikeda M; Yamamoto H; Hosoya T
    Ther Apher Dial; 2014 Feb; 18(1):68-73. PubMed ID: 24499086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can radiological assessment of abdominal computerized scans diagnose encapsulating peritoneal sclerosis in long-term peritoneal dialysis patients?
    Stuart S; Stott D; Goode A; Cash CJ; Davenport A
    Nephrology (Carlton); 2017 Jan; 22(1):19-24. PubMed ID: 26730546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Matrix Metalloproteinase-2-Based Nomogram to Assess the Risk of Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients.
    Chou CY; Tseng CC; Chen JB; Hung CC; Huang CC
    Biomed Res Int; 2021; 2021():6666441. PubMed ID: 33532492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis.
    Yamamoto T; Nagasue K; Okuno S; Yamakawa T
    Perit Dial Int; 2010; 30(3):343-52. PubMed ID: 20338969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients After Kidney Transplantation.
    Ayar Y; Ersoy A; Ocakoglu G; Gullulu E; Kagızmanlı H; Yıldız A; Oruc A; Yavuz M; Gullulu M; Dilek K
    Transplant Proc; 2018; 50(1):160-164. PubMed ID: 29407302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent.
    Zavvos V; Buxton AT; Evans C; Lambie M; Davies SJ; Topley N; Wilkie M; Summers A; Brenchley P; Goumenos DS; Johnson TS
    Kidney Int; 2017 Oct; 92(4):988-1002. PubMed ID: 28673451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment.
    Yamamoto R; Nakayama M; Hasegawa T; Miwako N; Yamamoto H; Yokoyami K; Ikeda M; Kato N; Hayakawa H; Takahashi H; Otsuka Y; Kawaguchi Y; Hosoya T
    Adv Perit Dial; 2002; 18():131-4. PubMed ID: 12402604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional patterns in peritoneal tissue of encapsulating peritoneal sclerosis, a complication of chronic peritoneal dialysis.
    Reimold FR; Braun N; Zsengellér ZK; Stillman IE; Karumanchi SA; Toka HR; Latus J; Fritz P; Biegger D; Segerer S; Alscher MD; Bhasin MK; Alper SL
    PLoS One; 2013; 8(2):e56389. PubMed ID: 23418565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal equilibration test with conventional 'low pH/high glucose degradation product' or with biocompatible 'normal pH/low glucose degradation product' dialysates: does it matter?
    Van Overmeire L; Goffin E; Krzesinski JM; Saint-Remy A; Bovy P; Cornet G; Bovy C
    Nephrol Dial Transplant; 2013 Jul; 28(7):1946-51. PubMed ID: 23223220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent sterile peritoneal inflammation after catheter removal for refractory bacterial peritonitis predicts full-blown encapsulating peritoneal sclerosis.
    Wong YY; Wong PN; Mak SK; Chan SF; Cheuk YY; Ho LY; Lo KY; Lo MW; Lo KC; Tong GM; Wong AK
    Perit Dial Int; 2013; 33(5):507-14. PubMed ID: 23907832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periostin: a matricellular protein involved in peritoneal injury during peritoneal dialysis.
    Braun N; Sen K; Alscher MD; Fritz P; Kimmel M; Morelle J; Goffin E; Jörres A; Wüthrich RP; Cohen CD; Segerer S
    Perit Dial Int; 2013; 33(5):515-28. PubMed ID: 23378472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal dialysis patients with high effluent fibrin degradation products.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2009; 25():41-4. PubMed ID: 19886315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Encapsulating Peritoneal Sclerosis in Long-Termed Peritoneal Dialysis Patients.
    Hsu HJ; Yang SY; Wu IW; Hsu KH; Sun CY; Chen CY; Lee CC
    Biomed Res Int; 2018; 2018():8250589. PubMed ID: 30539021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made.
    Lambie ML; John B; Mushahar L; Huckvale C; Davies SJ
    Kidney Int; 2010 Sep; 78(6):611-8. PubMed ID: 20571473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encapsulated peritoneal sclerosis: a single center, retrospective analysis of clinical manifestations, risk factors and prognosis.
    Koc Y; Basturk T; Sakaci T; Caglayan FB; Hasbal NB; Ahbap E; Sevinc M; Sinangil A; Ucar ZA; Nazif P; Islam M; Unsal A
    Minerva Urol Nefrol; 2018 Aug; 70(4):429-436. PubMed ID: 29478308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis.
    Vidal E; Edefonti A; Puteo F; Chimenz R; Gianoglio B; Lavoratti G; Leozappa G; Maringhini S; Mencarelli F; Pecoraro C; Ratsch IM; Cannavò R; De Palo T; Testa S; Murer L; Verrina E;
    Nephrol Dial Transplant; 2013 Jun; 28(6):1603-9. PubMed ID: 23585587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Categorization of sodium sieving by 2.27% and 3.86% peritoneal equilibration tests--a comparative analysis in the clinical setting.
    Gomes AM; Fontán MP; Rodríguez-Carmona A; Sastre A; Cambre HD; Muñiz AL; Falcón TG
    Nephrol Dial Transplant; 2009 Nov; 24(11):3513-20. PubMed ID: 19570887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrin degradation products are a useful marker for the risk of encapsulating peritoneal sclerosis.
    Moriishi M; Kawanishi H
    Adv Perit Dial; 2008; 24():56-9. PubMed ID: 18986002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum beta2 microglobulin (beta2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients.
    Yokoyama K; Yoshida H; Matsuo N; Maruyama Y; Kawamura Y; Yamamoto R; Hanaoka K; Ikeda M; Yamamoto H; Nakayama M; Kawaguchi Y; Hosoya T
    Clin Nephrol; 2008 Feb; 69(2):121-6. PubMed ID: 18218305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.